Artwork

Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
Player FM - Podcast-sovellus
Siirry offline-tilaan Player FM avulla!

Dana Watt | A Neuroscientist's Guide to Starting a Company

52:09
 
Jaa
 

Manage episode 432016951 series 2943147
Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Watt is an investment associate at Ascension Ventures, an investment firm specializing in healthcare technology. She previously co-founded and served as CSO of Pro-Arc Diagnostics, a personalized medicine company operating in St. Louis.


Key Highlights

Watt discusses her career journey and insights into venture capital investing in neuroscience and neurotech companies. She explains her role as a VC, which involves making profitable investments, underwriting risk, and structuring deals. Dana highlights key attributes of venture-backable companies, such as exceptional teams, large addressable markets, defensibility, and differentiation. She also discusses challenges and biases in neuroscience investing, including the complexity of brain science, hardware difficulties, long clinical timelines, and subtle readouts.


About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 jaksoa

Artwork
iconJaa
 
Manage episode 432016951 series 2943147
Sisällön tarjoaa Foresight Institute. Foresight Institute tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.

Dr. Watt is an investment associate at Ascension Ventures, an investment firm specializing in healthcare technology. She previously co-founded and served as CSO of Pro-Arc Diagnostics, a personalized medicine company operating in St. Louis.


Key Highlights

Watt discusses her career journey and insights into venture capital investing in neuroscience and neurotech companies. She explains her role as a VC, which involves making profitable investments, underwriting risk, and structuring deals. Dana highlights key attributes of venture-backable companies, such as exceptional teams, large addressable markets, defensibility, and differentiation. She also discusses challenges and biases in neuroscience investing, including the complexity of brain science, hardware difficulties, long clinical timelines, and subtle readouts.


About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 jaksoa

All episodes

×
 
Loading …

Tervetuloa Player FM:n!

Player FM skannaa verkkoa löytääkseen korkealaatuisia podcasteja, joista voit nauttia juuri nyt. Se on paras podcast-sovellus ja toimii Androidilla, iPhonela, ja verkossa. Rekisteröidy sykronoidaksesi tilaukset laitteiden välillä.

 

Pikakäyttöopas